$93 Profit
NKLong Stock
NantKwest, Inc., a clinical-stage immunotherapy company, develops immunotherapeutic treatments for cancer and viral infectious diseases in the United States.
Broker:Interactive Brokers
| Date | Price | |
|---|---|---|
| Entry | 2/12/2021 | 30.00 |
| Exit | 2/12/2021 | 30.70 |
- Total Views152
- Position Size133
- Percentage2.33%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
